Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma

Fuest, Sebastian; Post, Christoph; Balbach, Sebastian T.; Jabar, Susanne; Neumann, Ilka; Schimmelpfennig, Sandra; Sargin, Sarah; Nass, Elke; Budde, Thomas; Kailayangiri, Sareetha; Altvater, Bianca; Ranft, Andreas; Hartmann, Wolfgang; Dirksen, Uta; Rossig, Claudia; Schwab, Albrecht; Pethő, Zoltán (2022)

In: Cancers, 14(19), 4819.

Research article (journal)

SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma

Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019)

In: Clinical Cancer Research, 2019.

Research article (journal)

Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.

Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C (2017)

In: OncoImmunology, 6(1).

Research article (journal)

FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma

Trautmann M., Menzel J., Bertling C., Cyra M., Isfort I., Steinestel K., Elges S., Grünewald I., Altvater B., Rossig C., Fröhling S., Hafner S., Simmet T., Åman P., Wardelmann E., Huss S., Hartmann W. (2017)

In: Clinical Cancer Research, 23(20).

Research article (journal)

Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

Schliemann C, Gutbrodt KL, Kerkhoff A, Pohlen M, Wiebe S, Silling G, Angenendt L, Kessler T, Mesters RM, Giovannoni L, Schäfers M, Altvater B, Rossig C, Grünewald I, Wardelmann E, Köhler G, Neri D, Stelljes M, Berdel WE (2015)

In: Cancer immunology research, 3(5).

Research article (journal)

Publications

Contact

Top-Links

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma Fuest, Sebastian; Post, Christoph; Balbach, Sebastian T.; Jabar, Susanne; Neumann, Ilka; Schimmelpfennig, Sandra; Sargin, Sarah; Nass, Elke; Budde, Thomas; Kailayangiri, Sareetha; Altvater, Bianca; Ranft, Andreas; Hartmann, Wolfgang; Dirksen, Uta; Rossig, Claudia; Schwab, Albrecht; Pethő, Zoltán (2022) In: Cancers, 14(19), 4819. Research article (journal)
Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019. Research article (journal)
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019. Research article (journal)
Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019) In: Molecular Cancer Therapeutics, 2019. Research article (journal)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C (2017) In: OncoImmunology, 6(1). Research article (journal)
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2). Research article (journal)
FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma Trautmann M., Menzel J., Bertling C., Cyra M., Isfort I., Steinestel K., Elges S., Grünewald I., Altvater B., Rossig C., Fröhling S., Hafner S., Simmet T., Åman P., Wardelmann E., Huss S., Hartmann W. (2017) In: Clinical Cancer Research, 23(20). Research article (journal)
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies. Roellecke K, Virts EL, Einholz R, Edson KZ, Altvater B, Rossig C, von Laer D, Scheckenbach K, Wagenmann M, Reinhardt D, Kramm CM, Rettie AE, Wiek C, Hanenberg H (2016) In: Gene Therapy, 23(7). Research article (journal)
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation Schliemann C, Gutbrodt KL, Kerkhoff A, Pohlen M, Wiebe S, Silling G, Angenendt L, Kessler T, Mesters RM, Giovannoni L, Schäfers M, Altvater B, Rossig C, Grünewald I, Wardelmann E, Köhler G, Neri D, Stelljes M, Berdel WE (2015) In: Cancer immunology research, 3(5). Research article (journal)
Insulin-like growth factor-1 receptor (IGF-1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. Jamitzky S., Krueger A. C., Janneschütz S., Piepke S., Kailayangiri S., Spurny C., Rossig C., Altvater B. (2015) In: ((Bitte Journal prüfen)), 62(11). Research article (journal)